Loading...

loading icon

Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids

by / No Comments / 0 View / September 5, 2018

By Lisa Bernard-Kuhn

Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis. Under the deal, announced Tuesday, Ginkgo, which creates customized microbes, will work exclusively with Cronos to research and design microorganisms capable of producing cannabinoids. According to a Cronos news release, […]

Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

…read more

Via: Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids